Jim Hoffman: New Potential Predictive Biomarker for Lupus Nephritis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Lupus Foundation of America’s post on LinkedIn about a recent article by Eline Jana Arends et al., published in Lupus Science and Medicine, adding:
”I find it incomprehensible at this point, given all the evidence that NETs exacerbate flares, that they are not being routinely prognostically tracked in the clinic and treated to minimize the severity of Lupus flares that can accelerate irreversible tissue and organ damage, particularly as the severity of the condition worsens and becomes increasingly refractory to systemic drug treatments.
New Potential Predictive Biomarker for Lupus Nephritis
Abstract: NET load as a novel biomarker of autoimmune activity and flare risk in SLE
What better way to study the NET effect, not only as a predictive prognostic indicator but as a highly valued clinical theranostic/theragnostic marker for direct and potentially improved treatment using this extracorporeal NET removal therapy, which can most likely also be applied to the treatment of many other lupus-like autoimmune diseases/syndromes.”
Lupus Foundation of America shared a post on LinkedIn:
”A new study finds people with systemic autoimmune rheumatic diseases like lupus and clinicians describe flares differently, especially in how quickly they start, how they are recognized, and whether they require changes in treatment.”
Title: NET load as a novel biomarker of autoimmune activity and flare risk in SLE
Authors: Eline Jana Arends, Rudmer J Postma, Sandra Van Der Kooij, Sylvia WA Kamerling, Maarten Limper, Alexandre E Voskuijl, Karina De Leeuw, Luuk B Hillbrands, Johan H Van Der Vlag, Marc Bijl, Ton J Rabelink, Cees Van Kooten, YK Onno Teng

Other posts featuring Jim Hoffman on Hemostasis Today.
-
Nov 12, 2026, 14:35Mokhtar Tazik: Connecting Clinical Demand with Plasma Collection and Fractionation Capacity
-
Nov 12, 2026, 14:25Kim Phelan: Celebrating Dr. Marilyn Manco-Johnson as a Recipient of the 2026 Eternal Spirit Award
-
Nov 12, 2026, 14:20Shailesh Kucha: Ensuring Transfusion Safety Through Biochemical Assessment of Stored Red Cells
-
Nov 12, 2026, 14:20Akshat Jain: Wonderful Time Presenting at the ATHN 2026
-
Nov 12, 2026, 14:08Elisa Gabinaud: The Evolving Science of Megakaryocyte Development
-
Nov 12, 2026, 13:57Seyed Mohammad Sadegh Pezeshki: When Microcytosis Reveals a Complex Hemoglobinopathy
-
Nov 12, 2026, 13:45Danny Hsu: THANZ Highlights Antiphospholipid Syndrome in Upcoming Educational Webinar
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH
-
Nov 12, 2026, 13:00Abdul Mannan: Factor IX Prophylaxis – Can Breakthrough Bleeding Still Occur?